Trace Biosciences is creating imaging agents for surgery. Our mission is to revolutionize surgery by highlighting detailed anatomy in real-time. Our first product is a nerve targeting imaging agent that will prevent surgical nerve damage. Nerve injury is a feared surgical complication affecting 25 million patients annually and incurring undue pain, loss of function, and high cost for follow on treatment and pain management. Currently, surgeons are entirely unassisted and nerves are invisible, causing surgeons to guess their location using anatomical landmarks. If we can successfully develop this, our imaging agents will be used in almost all operating theaters, so surgeons can cut by color, not by guesswork.
| Website | https://trace-bio.com |
| Employees | 11 (8 on RocketReach) |
| Founded | 2021 |
| Address | 1800 NW 167th Pl, Beaverton, Oregon 97006, US |
| Phone | +1 971-202-0545 |
| Industry | Biotechnology Research |
| Competitors | Johnson & Johnson, Roche, Pfizer, Sanofi, GSK, AstraZeneca, Regeneron, Moderna Therapeutics, Novavax, CureVac +40 more (view full list) |
Looking for a particular Trace Biosciences employee's phone or email?
Connor Barth is the Co-Founder and CEO of Trace Biosciences.
8 people are employed at Trace Biosciences.
Trace Biosciences is based in Beaverton, Oregon.